セッション情報

FACO International Workshop

第53回・2015年・京都
FACO International Workshop
FACO International Workshop 2
Colorectal Cancer 1: Clinical Trial
開催回
第53回・2015年・京都

Effectiveness of bevacizumab beyond progression to UFT, oral leucovorin and irinotecan, combination therapy (TEGAFIRI) + bevacizumab in metastatic colorectal cancer: Randomized KODK7 trial

演題番号 : FWS2-1

Shigeta Kohei:1、Hasegawa Hirotoshi:1、Okabayashi Koji:1、Tsuruta Masashi:1、Kitagawa Yuko:1

1:Department of Surgery, School of Medicine, Keio University

Effectiveness of bevacizumab beyond progression to UFT, oral leucovorin and irinotecan, combination therapy (TEGAFIRI) + bevacizumab in metastatic colorectal cancer: Randomized KODK7 trial

Efficacy and feasibility of aprepitant in colorectal cancer patients receiving oxaliplatin-based chemotherapy (Phase III SENRI Trial)

演題番号 : FWS2-2

Nakata Ken:1、Nishimura Junichi:2、Satoh Taroh:3、Yasui Masayoshi:4、Takemoto Hiroyoshi:5、Fukuzaki Takayuki:6、Ide Yoshihito:7、Miyake Yasuhiro:8、Kudo Toshihiro:3、Hata Taishi:2、Takemasa Ichiro:2、Mizushima Tsunekazu:9、Yamamoto Hirofumi:10、Doki Yuichiro:2、Mori Masaki:2

1:Department of Surgery, Sakai City Hospital、2:Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University、3:Department of Frontier-Science for Cancer and Chemotherapy, Graduate School of Medicine, Osaka University、4:Department of Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases、5:Department of Surgery, Kinki Central Hospital、6:Department of Surgery, Saiseikai Senri Hospital、7:Department of Surgery, Yao Municipal Hosptal、8:Department of Surgery, Nishinomiya Municipal Central Hospital、9:Department of Inflammatory Bowel Diseases, Graduate School of Medicine, Osaka University、10:Department of Molecular Pathology, Graduate School of Medicine, Osaka University

Efficacy and feasibility of aprepitant in colorectal cancer patients receiving oxaliplatin-based chemotherapy (Phase III SENRI Trial)

Autologous cytokine-induced killer cells combined with chemotherapy in the first line treatment of metastatic colorectal carcinoma: A prospective randomized controlled clinical study

演題番号 : FWS2-3

Ding Zhenyu:1、Piao Ying:1、Zhen Zhendong:1、Yu Huiying:2、Ma Dongchu:2、Xie Xiaodong:1

1:Department of Oncology, General Hospital of Shenyang Military Region、2:Department of Experimental Medicine, General Hospital of Shenyang Military Region

Autologous cytokine-induced killer cells combined with chemotherapy in the first line treatment of metastatic colorectal carcinoma: A prospective randomized controlled clinical study

Effect of DPYD and MTHFR gene polymorphisms on the response and toxicity of 5-fluorouracil based chemotherapy in the colorectal cancer patients

演題番号 : FWS2-4

Islam Mohammad Safiqul:1,2、Nahid Noor Ahmed:3、Ahmed Maizbha Uddin:3、Islam Md. Siddiqul:3、Yokota Kazushige:1、Hasnat Abul:3

1:Dept. Life Sci. Biotechnol., Shimane University, Japan、2:Deptartment of Pharmacy, Noakhali Sci. and Techn. University., Bangladesh、3:Deptartment of Clinical Pharm. and Pharmaco., University of Dhaka, Bangladesh

Effect of DPYD and MTHFR gene polymorphisms on the response and toxicity of 5-fluorouracil based chemotherapy in the colorectal cancer patients

The impact of Glasgow plognostic score on the recurrence of colorectal cancer

演題番号 : FWS2-5

Kondo Takayuki:1、Okabayashi Koji:1、Hasegawa Hirotoshi:1、Tsuruta Masashi:1、Shigeta Kohei:1、Shimada Takehiro:1、Matsuda Mutsuhito:1、Yahagi Masashi:1、Yoshikawa Yusuke:1、Kitagawa Yuko:1

1:Surgery, School of Medicine, Keio University

The impact of Glasgow plognostic score on the recurrence of colorectal cancer